Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Prevention »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Prevalence < Prevention < Previous study  Facettes :

List of bibliographic references indexed by Prevention

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000C02 (2014) Sarah Koch [Allemagne, Canada] ; Michael Cassel [Allemagne] ; Karsten Linne [Allemagne] ; Frank Mayer [Allemagne] ; Jürgen Scharhag [Allemagne]ECG and echocardiographic findings in 10-15-year-old elite athletes
001040 (2013) Hong-Lei Li [République populaire de Chine] ; Shen-Ji Lu [République populaire de Chine] ; Yi-Min Sun [République populaire de Chine] ; Qi-Hao Guo [République populaire de Chine] ; Adele Dessa Sadovnick [Canada] ; Zhi-Ying Wu [République populaire de Chine]The LRRK2 R1628P Variant Plays a Protective Role in Han Chinese Population with Alzheimer's Disease
001D30 (2010) C. Gibrat [Canada] ; M. Bousquet [Canada] ; M. Saint-Pierre [Canada] ; D. Levesque [Canada] ; F. Calon [Canada] ; C. Rouillard [Canada] ; F. Cicchetti [Canada]Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor
002638 (2007) Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada]Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
002653 (2007) YU YAO [Canada] ; Amandio Vieira [Canada]Protective activities of Vacciniutn antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity
002805 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
002945 (2006) Alan S. Hazell [Canada] ; Louise Normandin [Canada] ; Michael D. Norenberg [États-Unis] ; Gregory Kennedy [Canada] ; Jae-Hyuk Yi [Canada]Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment
002F47 (2003) Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada]Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys
003277 (2001) Ali H. Rajput [Canada]The protective role of levodopa in the human substantia nigra
003332 (2001) ABDALLAH HADJ TAHAR [Canada] ; Anna Ekesbo [Suède] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Kjell A. Svensson [États-Unis] ; Joakim Tedroff [Suède] ; Paul J. Bedard [Canada]Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys
003334 (2001) Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël]Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression
003599 (2000) O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada]A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa
003B63 (1997) Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada]R(−)-Deprenyl Potentiates Dopamine-Induced Cytotoxicity toward Catecholaminergic Neuroblastoma SH-SY5Y Cells
003C74 (1997) K. Rabheru [Canada] ; E. Persad [Canada]A review of continuation and maintenance electroconvulsive therapy
003E89 (1996) N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada]Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone
004302 (1994) P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. BedardExcitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys
004984 (1990) G. M. Guiraudon ; G. J. Klein ; R. Yee ; R. Kaushik ; D. G. Mclellan ; D. M. CadeSurgical epicardial ablation of left ventricular pathway using sling exposure
004A04 (1990) E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. CalneClozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis
004D81 (1987) T. L. Perry ; VOON WEE YONG ; S. Hansen ; K. Jones ; C. Bergeron ; J. G. Foulks ; J. M. Wrightα-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Prevention" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Prevention" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Prevention
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022